Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:304 (4 February), doi:10.1136/bmj.332.7536.304
| The first 150 words of the full text of this article appear below. |
EDITORRobinson says that diagnosis of pulmonary embolism can be difficult but does not mention the available scoring systems that are useful in defining the likelihood of pulmonary thromboembolism.1 2 Most importantly, she makes no mention of biomarkers and does not emphasise the critical importance of echocardiography or computed tomography scanning to identify right ventricular strain.
| |||||||||||
Patients with a raised troponin concentration (I or T) and echo or computed tomographic evidence of right ventricular overload have 10 times the risk of death or major adverse event than individuals with a normal troponin value and normal right ventricular function.3 4
Importantly, the recommendation of low molecular weight heparin as initial treatment for all applies only to stable patients. Patients with shock should receive intravenous heparin, since cutaneous perfusion is compromised, and low molecular weight heparin may not be absorbed.
Finally, Robinson makes no mention of life saving surgical embolectomy or percutaneous fragmentation
Adrian J B Brady, consultant cardiologist
Glasgow Royal Infirmary, Glasgow G31 2ER a.j.brady@clinmed.gla.ac.uk
Read all Rapid Responses